Concepts (70)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sarcopenia | 2 | 2021 | 34 | 1.400 |
Why?
|
| Thoracic Wall | 1 | 2021 | 11 | 0.780 |
Why?
|
| Muscle, Skeletal | 2 | 2021 | 370 | 0.690 |
Why?
|
| Esophagectomy | 1 | 2019 | 24 | 0.670 |
Why?
|
| Esophageal Neoplasms | 1 | 2019 | 49 | 0.650 |
Why?
|
| Postoperative Complications | 1 | 2019 | 991 | 0.420 |
Why?
|
| Lung Neoplasms | 4 | 2024 | 691 | 0.420 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2021 | 817 | 0.230 |
Why?
|
| Body Composition | 1 | 2024 | 67 | 0.230 |
Why?
|
| Benchmarking | 1 | 2021 | 46 | 0.190 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 356 | 0.180 |
Why?
|
| Calcinosis | 1 | 2020 | 50 | 0.170 |
Why?
|
| Dyspnea | 1 | 2020 | 44 | 0.170 |
Why?
|
| Lung Diseases | 1 | 2020 | 50 | 0.170 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2019 | 13 | 0.160 |
Why?
|
| Prognosis | 2 | 2019 | 919 | 0.160 |
Why?
|
| False Positive Reactions | 1 | 2019 | 36 | 0.160 |
Why?
|
| Unnecessary Procedures | 1 | 2019 | 28 | 0.160 |
Why?
|
| Kidney Transplantation | 1 | 2020 | 126 | 0.150 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 101 | 0.150 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2019 | 192 | 0.140 |
Why?
|
| Cachexia | 1 | 2017 | 14 | 0.140 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2017 | 45 | 0.140 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2017 | 33 | 0.140 |
Why?
|
| Humans | 8 | 2024 | 30959 | 0.130 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 337 | 0.120 |
Why?
|
| Retrospective Studies | 2 | 2021 | 3658 | 0.120 |
Why?
|
| Publishing | 1 | 2014 | 42 | 0.120 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 225 | 0.110 |
Why?
|
| Aged | 4 | 2024 | 10047 | 0.110 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 230 | 0.110 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2013 | 10 | 0.110 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2013 | 14 | 0.110 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2013 | 11 | 0.110 |
Why?
|
| Biomarkers, Tumor | 1 | 2013 | 217 | 0.090 |
Why?
|
| Neoplasm Staging | 2 | 2024 | 404 | 0.090 |
Why?
|
| Cytokines | 1 | 2013 | 351 | 0.090 |
Why?
|
| Pneumonia | 2 | 2019 | 75 | 0.060 |
Why?
|
| Middle Aged | 4 | 2024 | 10192 | 0.060 |
Why?
|
| Male | 5 | 2024 | 16425 | 0.060 |
Why?
|
| Body Weight | 1 | 2024 | 141 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2024 | 452 | 0.050 |
Why?
|
| Female | 4 | 2024 | 16965 | 0.050 |
Why?
|
| Mediastinoscopy | 1 | 2019 | 5 | 0.040 |
Why?
|
| Thoracoscopy | 1 | 2019 | 20 | 0.040 |
Why?
|
| Bronchoscopy | 1 | 2019 | 30 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 407 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2019 | 89 | 0.040 |
Why?
|
| Disease Progression | 1 | 2020 | 830 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 208 | 0.030 |
Why?
|
| Weight Loss | 1 | 2017 | 117 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 368 | 0.030 |
Why?
|
| Software | 1 | 2014 | 72 | 0.030 |
Why?
|
| Lung | 1 | 2014 | 173 | 0.030 |
Why?
|
| Chemokine CCL3 | 1 | 2013 | 14 | 0.030 |
Why?
|
| Granuloma | 1 | 2013 | 15 | 0.030 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2013 | 17 | 0.030 |
Why?
|
| Chemokine CXCL12 | 1 | 2013 | 9 | 0.030 |
Why?
|
| Respiratory Tract Infections | 1 | 2013 | 24 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2013 | 70 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2013 | 39 | 0.030 |
Why?
|
| ROC Curve | 1 | 2013 | 145 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2013 | 112 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 817 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 234 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 549 | 0.020 |
Why?
|
| Radiography | 1 | 2013 | 695 | 0.020 |
Why?
|
| Young Adult | 1 | 2013 | 2060 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 5189 | 0.010 |
Why?
|
| Adult | 1 | 2013 | 8924 | 0.010 |
Why?
|